Preventing the spread of HIV in injecting drug users--the experience of syringe-exchange schemes in England and Scotland.

Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Preventing the spread of HIV in injecting drug users--the experience of syringe-exchange schemes in England and Scotland.

NIDA Res Monogr. 1988;90:302-10. Unique Identifier : AIDSLINE MED/90043973
Stimson G; Alldritt L; Dolan K; Donoghoe M; Monitoring Research Group, University of London Goldsmiths'; College, UK.

Abstract: In 1987 the UK government launched experimental schemes for distributing injecting equipment to injecting drug users in order to help prevent the spread of Human Immunodeficiency Virus. This paper reports on the first few months of the schemes, and provides some initial evidence of changes in clients' risk behaviours. The schemes have been reasonably successful in attracting clients, but are less successful in retaining them. Schemes have demonstrated that equipment can be distributed to clients on an exchange basis. Schemes have reached new groups of clients, including many without previous or current treatment contact or other help for their drug problems. The baseline assessment of clients found that most had accurate knowledge of the risk of infection from sharing injecting equipment. Most thought that they were at low risk of infection. Syringe sharing in the last four weeks was reported by 36%. A minority engaged in multiple sharing. Most clients were sexually active and many had partners who did not inject drugs. The main reason for attendance was worry about AIDS, and a majority of clients reported that they had already made changes in their injecting practices because of AIDS. Some reported changes in sexual behaviour. A sample of clients followed-up at 2-4 months indicates a reduction in syringe sharing.

Keywords: Acquired Immunodeficiency Syndrome/*PREVENTION & CONTROL/ TRANSMISSION Adolescence Adult England Female *Health Policy Human Male Middle Age Risk Factors Scotland Sex Behavior *Substance Abuse, Intravenous Support, Non-U.S. Gov't *Syringes JOURNAL ARTICLE
900228
M9020556

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .